TH
IONS icon

Timber Hill’s Ionis Pharmaceuticals IONS Stock Holding History

Timber Hill’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,800
Closed -$295K – 783
2017
Q2 		$295K Sell
5,800
-34,600
-86% -$1.61M 0.01% 730
2017
Q1 		$1.62M Sell
40,400
-59,500
-60% -$2.67M 0.01% 807
2016
Q4 		$4.78M Buy
99,900
+48,000
+92% +$1.9M 0.02% 544
2016
Q3 		$1.9M Sell
51,900
-12,500
-19% -$391K 0.01% 822
2016
Q2 		$1.5M Sell
64,400
-14,200
-18% -$458K 0.01% 1039
2016
Q1 		$3.18M Buy
78,600
+22,800
+41% +$926K 0.02% 703
2015
Q4 		$3.46M Sell
55,800
-57,800
-51% -$3.12M 0.02% 706
2015
Q3 		$4.59M Buy
113,600
+55,500
+96% +$2.87M 0.02% 596
2015
Q2 		$3.34M Sell
58,100
-60,700
-51% -$3.86M 0.02% 786
2015
Q1 		$7.56M Buy
118,800
+29,800
+33% +$2.02M 0.03% 414
2014
Q4 		$5.5M Buy
89,000
+8,800
+11% +$434K 0.02% 526
2014
Q3 		$3.11M Buy
80,200
+29,600
+58% +$1.05M 0.01% 867
2014
Q2 		$1.74M Sell
50,600
-37,900
-43% -$1.19M 0.01% 1267
2014
Q1 		$3.82M Buy
88,500
+5,700
+7% +$276K 0.02% 769
2013
Q4 		$3.3M Sell
82,800
-39,500
-32% -$1.41M 0.01% 1024
2013
Q3 		$4.59M Buy
122,300
+58,100
+90% +$1.74M 0.02% 905
2013
Q2 		$1.73M Buy
+64,200
New +$1.37M 0.01% 1549

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Timber Hill's IONS Position: Q1 2017 in Review

Timber Hill sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 8,721 shares — an estimated $392K sold.

Timber Hill first reported a position in IONS in Q2 2013 and held it in 7 quarters. The position peaked at $1.02M in Q3 2016. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

  • Timber Hill reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Timber Hill sold 8,721 Ionis Pharmaceuticals shares in Q1 2017, an estimated $392K.
  • Timber Hill first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Timber Hill's Ionis Pharmaceuticals position peaked at $1.02M in Q3 2016.
  • 270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Timber Hill's 13F filing for Q1 2017, filed 10 May 2017.